Cynata Therapeutics Limited (AU:CYP) has released an update.
Cynata Therapeutics Limited has reported a change in the interests of Director Dr. Kilian Kelly, specifically relating to the expiry of 1,000,000 unlisted options. Post this change, Dr. Kelly retains 477,373 ordinary shares and still holds a significant number of unlisted and listed options, some exercisable until 2028. No new interests were acquired, and there were no changes in director’s interests in contracts.
For further insights into AU:CYP stock, check out TipRanks’ Stock Analysis page.
